Sansure Biotech
Business Services · China · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
no.680 Lusong Road hi-Tech Development Z...Phone Number
+86 73188884876Website
www.sansure.com.cnRevenue
$97.7 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Sansure Biotech
Based on innovative R&D center in Changsha, China, Sansure understands its capability and social responsibility to offer molecular diagnostic products consistent in quality, accurate and reliable in test results, easy to use and accessible to laboratories of all levels despite their variety in lab environment. Sansure is gradually winning its reputation all over the world and exerting growing influence on popularizing qPCR technologies towards what they are supposed to be as affordable and accessible human health care means. Sansure started domestic sales in 2008, and by the end of 2016 had ranked No.2 in terms of market share in China with more than 1000 hospitals and laboratories contributing to daily consumption of over 50,000 tests. In 2016, eight out of the ten top hospitals specialized in infectious diseases are Sansure loyal clients. Globally, Sansure innovative technologies now have been introduced into more than 30 countries and regions including Europe, Middle East, Asia, AfrRead more
Sansure Biotech Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Sansure Biotech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Sansure Biotech
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Sansure Biotech has recently received funding, and reach out quickly before it becomes old news!
Check out if Sansure Biotech is spiking on competitors!
Funding: Get notified immidiatlly once Sansure Biotech has new funding data
Sansure Biotech, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Sansure Biotech had a recent Job posting/layoffs
Earning: See what the market has to say on Sansure Biotech recently announced quarterly report
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Sansure Biotech launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Sansure Biotech is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Sansure Biotech is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Sansure Biotech.
Sansure Biotech financials insights
Gather financial insights about Sansure Biotech, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2018
Private Equity
$77M
2020
Stock Offering
$294.2M
Sansure Biotech Tech Stack
A closer look at the technologies used by Sansure Biotech
Sansure Biotech News & Media
Asep Inc. Signs Joint Venture Term Sheet with Leading Chinese Medical Diagnostic Company Sansure Biotech Inc. in Preparation for the Commercialization of the Sepset(ER) Sepsis Diagnostic Test in China
VANCOUVER, BC, Jan. 27, 2023 /PRNewswire/ - Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE: ASEP) (OTCQB: SEPSF) is pleased to announce that it has signed a joint venture term sheet with a leading Chinese medical diagnostic company, Sansure Biotech Inc. (Sansure). The term...QuantuMDx Enters into Cooperation Agreement with Sansure Biotech
QuantuMDx Enters into Cooperation Agreement with Sansure BiotechQuantuMDx secures £15 million equity investment from Vita Spring and enters into ...
QuantuMDx secures £15 million equity investment from Vita Spring and enters into Cooperation Agreement discussions with Sansure Biotech Funds will be used to develop further multiplexing capabilities and menu expansion in collaboration with Sansure, on the Q-POC™ deviceCooperation Agreement to accelerate regional commercialisation of Q-POC™ and its cassettes in China and other South-East Asian markets as well as offering potential for manufacturing optimisation and broadening of Q-POC™ assay por
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Sansure Biotech
Sign Up For FreeTo access detailed company insights
Based on innovative R&D center in Changsha, China, Sansure understands its capability and social responsibility to offer molecular diagnostic products consistent in quality, accurate and reliable in test results, easy to use and accessible to laboratories of all levels despite their variety in lab environment. Sansure is gradually winning its reput... Read More
